Ebitda Alterar Data
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Avita Medical AUD -5.56M 4.13M 2026-06
Celltrion KRW 25.72B 6.08B 2026-06
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -61.38M 14.92M 2026-06
Divis Laboratories Ltd INR 15.66B 3.04B 2026-09
IQVIA Holdings USD 1.03B 38M 2026-09
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Moderna USD -687M 571M 2026-06
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Organigram Holdings CAD 15.45M 20.21M 2026-06
Organon & Co USD 502M 131M 2026-09
Pharma Mar EUR 9.63M 8.93M 2026-09
Qiagen NV USD 219.78M 12.13M 2026-09
Revvity USD 227.55M 629K 2026-09
Sartorius EUR 279.9M 600K 2026-09
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
Tilray USD 8.36M 1.82M 2025-09
Viatris USD 1.2B 7.4M 2026-09
Xeris Pharmaceuticals USD -20.94M 33.27M 2026-06
Zealand Pharma A/S -379M 348.47M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 419.24M 463.46M 2026-06